NetworkNewsBreaks Archive - Page 1361 of 1739

WednesdayNov 21, 2018 9:18 am

NetworkNewsBreaks – DPW Holdings, Inc. (NYSE American: DPW) CEO and Chairman to Present at the LD Micro Main Event

Diversified holding company DPW Holdings (NYSE American: DPW) this morning announced that its CEO and Chairman, Milton "Todd" Ault, III will be presenting at the 11th Annual LD Micro Main Event on December 4, 2018 at 5 PM ET. Joining Ault, DPW Holdings CAO Kenneth S. Cragun and CEO of Digital Power Lending William "Billy" Corbett will be available for one-on-one meetings throughout the day. The event, which is anticipated to be attended by more than 1,200 individuals, will be held in Los Angeles at the Luxe Sunset Bel Air Hotel December 4 – 6, 2018, and is expected to…

TuesdayNov 20, 2018 2:54 pm

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Developing Health-oriented CBD Products

Biotechnology company Earth Science Tech (OTCQB: ETST) develops and markets health-oriented cannabinoid (“CBD”) products, such as its Hygee medical devices. A recent article discussing the company reads, “Hygee medical devices provide women access to cost-effective testing while protecting their privacy. This self-sampling kit allows woman to discreetly test for sexually transmitted infections (STIs). Similar to a feminine hygiene panty liner, the device is worn for four hours to collect a cervical cell sample. Once collected, the sample is then mailed to the Procrea Fertility lab where it is tested for STIs. This is a positive step forward for women who…

TuesdayNov 20, 2018 2:49 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Raises $1.5M in Private Placement to Fund Canadian Lab

British Columbia, Canada-based Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is a biotechnology company and developer of technology which has demonstrated faster and more effective delivery of cannabinoids and nicotine. Recently, LXRP raised funds through a non-brokered private placement that it intends to use toward the construction of a new Canadian lab, research & development and general corporate purposes. A recent article discussing the company reads, “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has raised, in a non-brokered private placement, a total of $1,515,440. Net proceeds will be used for construction of a new lab in Canada, LXRP-driven R&D and general…

TuesdayNov 20, 2018 1:11 pm

NetworkNewsBreaks – Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) Issues Corporate Update; Announces Helados Prospect Expansion

Mineral explorer Lithium Chile (TSX.V: LITH) (OTCQB: LTMCF) issued an operational update to its shareholders today including an announcement that the company will be expanding its Helados Prospect. Per the update, the company has acquired an additional 2000 hectares on the Salar Laguna Blanca which is a NW extension to Lithium Chile's landholdings in the Helados basin. Additionally, Lithium Chile provided updates concerning its Salar de Coipasa and Salar de Turi prospects. The company reported that it has successfully negotiated terms for surface access to the salar de Coipasa with the community executive and is currently waiting for final approval…

TuesdayNov 20, 2018 12:23 pm

NetworkNewsBreaks – Green Hygienics Holdings Inc.’s (GRYN) Cannagram Services to Drive Vertical Expansion

Green Hygienics Holdings (OTC: GRYN), a full-scope, premium cannabis company, sees its rebranded Cannagram Services as a key platform to generate strategic growth in vertical markets. An article discussing the company reads, “Cannagram Services, CoursePro Academy and Myijuana together advance GRYN’s strategy of expanding its product sales and exposure in the full-scope premium cannabis industry, targeting the top-end medical and adult-use recreational markets. Science-driven cannabis growing methods are linked to its proprietary systems, algorithms, software and customized hardware. In a commercial environment, GRYN uses hybrid-aeroponics cultivation to produce pharmaceutical grade cannabis at a high yield and low cost.” To view…

TuesdayNov 20, 2018 12:16 pm

NetworkNewsBreaks – Why Plus Products Inc. (CSE: PLUS) is “One to Watch”

Plus Products (CSE: PLUS) is a branded cannabis-infused products manufacturer headquartered in San Mateo, California. The company focusses on creating edibles using extracts to ensure compliant, consistent products. A recent article discussing the company reads, “Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up…

TuesdayNov 20, 2018 9:56 am

NetworkNewsBreaks – Marijuana Company of America Inc. (MCOA) Reports Q3 Financial Results, Revenue Trend

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) this morning announced financial results for the three and nine months ended September 30, 2018. The update noted the following highlights from Q3 2017 to Q3 2018: Increased revenues of 2984 percent; increased total assets by 42 percent; operations net loss decrease of 1057 percent; decrease in SG&A expenses by 1007 percent; and decrease in total liabilities by 259 percent. “The third quarter marked an important milestone for MCOA, as our hempSMART sales have ramped up due to our multi-pronged marketing campaign and several newly launched products,” MCOA CEO…

TuesdayNov 20, 2018 9:49 am

NetworkNewsBreaks – CytoDyn Inc.’s (CYDY) PRO 140 Assigned Leronlimab as Official Name by USAN Council

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) today announced that the United States Adopted Names (“USAN”) Council has designated leronlimab as the official name for its PRO 140. The investigational new drug has not yet been approved for any indication; however, CytoDyn is exploring partnering and licensing agreements for HIV treatment with intention to pursue use of leronlimab in cancer and other autoimmune diseases. “As we recently announced, we are very pleased with the results of our monotherapy higher dose of leronlimab 700 mg showing an impressive responder’s rate of over 90%,” CytoDyn President and Chief Executive Officer Dr. Nader Pourhassan…

TuesdayNov 20, 2018 9:20 am

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) President and CEO Featured in Uptick Newswire’s Stock Day Podcast

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences industry, this morning announced the featured interview of its president and CEO Richard T. Schumacher with Stock Day’s Everett Jolly. Among other highlights, Schumacher announced that the company has accomplished yet another important milestone in the advancement of its proprietary Ultra Shear Technology (“UST”) platform and commercialization program. Following the company’s recent news regarding the development of the first working prototype of the UST system, PBIO reported that it has developed a proprietary method…

MondayNov 19, 2018 2:07 pm

NetworkNewsBreaks – Aziza Project LLC Featured in Exclusive Audio Interview Discussing Tokenized Oil & Gas Fund

Aziza Project LLC, a fund that tokenizes high potential oil and gas businesses in Africa, today announced that it was featured in an exclusive audio interview from NetworkNewsWire. The interview, available at http://nnw.fm/m38zE, highlights the company’s innovative investment platform, completed milestones and strategies for continued growth. According to the release, Aziza’s accomplishments to date include its establishment of a dynamic leadership team, formation of its asset-backed security token, successful navigation of the regulatory environment and completion of all communications, marketing materials and the organization’s offering memorandum. Aziza Project CEO Robert Pyke indicated in the news release that, while much has…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks